The clinical research landscape for cannabinoid medicines continues to expand, with studies underway across a wide range of therapeutic areas. Here's a snapshot of the research that could shape the future of cannabis-based treatments.
Pain management
Chronic pain remains the most common condition for which patients seek medical cannabis. Several major trials are underway investigating the efficacy of different cannabinoid formulations for neuropathic pain, inflammatory pain, and pain associated with conditions like fibromyalgia.
Mental health
The role of cannabinoids in mental health treatment is one of the most active areas of research. Studies are exploring the potential of CBD for anxiety disorders, the role of cannabinoids in PTSD treatment, and the complex relationship between cannabis use and psychotic disorders.
Neurological conditions
Research into cannabinoids for neurological conditions continues to build on the evidence base that led to the first cannabis-based medicines being licensed. Epilepsy, multiple sclerosis, and Parkinson's disease all feature prominently in the current research pipeline.
What to watch
Key studies to watch include large-scale real-world evidence programmes tracking patient outcomes, randomised controlled trials in new therapeutic areas, and research into the entourage effect — the theory that cannabinoids and terpenes work more effectively together than in isolation.
